Surgical excision for recurrent herpes simplex virus 2 (HSV-2) anogenital infection in a patient with human immunodeficiency virus (HIV)

Infection. 2017 Oct;45(5):705-707. doi: 10.1007/s15010-017-1027-y. Epub 2017 May 15.

Abstract

Recurrent anogenital herpes simplex virus infections are common in patients with human immunodeficiency virus (HIV), of whom approximately 5% develop resistance to acyclovir. We present a case of a 49-year-old man with HIV who had an 8-year history of recurrent left inguinal herpes simplex virus type 2 ulcerations. He initially responded to oral acyclovir, but developed resistance to acyclovir and eventually foscarnet. The lesion progressed to a large hypertrophic mass that required surgical excision, which led to resolution without recurrences. Our case highlights the importance of surgical excision as a treatment option in refractory herpes simplex virus anogenital infections.

Keywords: HSV-1; HSV-2; Herpes simplex infection; Hypertrophic HSV herpes simplex vegetans; Recurrent herpes simplex infection.

Publication types

  • Case Reports

MeSH terms

  • Acyclovir / pharmacology*
  • Antiviral Agents / pharmacology*
  • Drug Resistance, Viral*
  • Foscarnet / pharmacology*
  • HIV Infections / complications
  • Herpes Genitalis / diagnosis
  • Herpes Genitalis / drug therapy*
  • Herpesvirus 2, Human / drug effects*
  • Humans
  • Male
  • Middle Aged

Substances

  • Antiviral Agents
  • Foscarnet
  • Acyclovir